Sitemap

Serbian Torlak Institute To Get Technology For Sputnik V Vaccine

More...

Production Of Sputnik V Launched In Serbia

The Russian Direct Investment Fund (RDIF, Russia’s...

Start Of The New EU For Local Development Programme – EU PRO Plus

EU PRO Plus, a new European Union...

Meeting Of The Head Of EU Delegation And The President Of Serbia

President of the Republic of Serbia Aleksandar...

News

Production Of Sputnik V Launched In Serbia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Institute of Virology, Vaccines and Sera “Torlak” announce...

Start Of The New EU For Local Development Programme – EU PRO Plus

EU PRO Plus, a new European Union programme for local development, which aims to contribute to the overall social...

Distribution Of Laptops And Tablets, Bridging Digital Divide In Serbia For The Most Vulnerable Children Project

The Head of the European Union Delegation to Serbia, Ambassador Sem Fabrizi, UNICEF Representative in Serbia, Deyana Kostadinova, and...

Meeting Of The Head Of EU Delegation And The President Of Serbia

President of the Republic of Serbia Aleksandar Vučić met today with the Head of the Delegation of the European...

U.S. Announces New USAID Development Cooperation Strategy With Serbia

On April 12, 2021, the Ministry for European Integration and the United States Government officially extended their development partnership...

Serbia’s Torlak Institute on Monday signed a technology transfer agreement with the Russian Direct Investment Fund and the Russian pharmaceuticals company Generium under which the Russian side will transfer to the Serbian side information on procedures and technologies required for production of the Sputnik V COVID-19 vaccine in Serbia.

The news was announced by Serbian Minister for Innovation Nenad Popovic, who also co-chairs a Serbian-Russian cooperation committee.

Popovic noted that sensitive information related to production of the Sputnik V was now available to the Torlak Institute, which he said would produce three validation series of the vaccine in April.

Samples of the series will be sent to Moscow’s Gamaleya Institute for quality control, he said.

If they pass validation, Torlak will start producing the vaccine, which is expected to happen by May 20.

Popovic said Serbia would thus become the first country in Europe to produce the Sputnik V vaccine.

“This is the start of the renewal of our country’s sovereignty when it comes to vaccine production, which will be an important resource for every state in the future,” Popovic said.

Source: tanjug, photo: sputnikvaccine.com

Related Articles

Production Of Sputnik V Launched In Serbia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Institute of Virology, Vaccines and Sera “Torlak” announce the launch of production of...

Vaccine Passports Are Sreading Across The World Here’s How They Could Work In The US

Vaccine passports are set to become a part of everyday life right across the world as governments race to vaccinate their populations against the...

Skopje Launches Mass Coronavirus Vaccination With Russia’s Sputnik V

Vaccines are available for police officers, Interior Ministry employees, pharmacists, pre-school and school teachers as well as other categories qualified as a critical group Mass...

Coronavirus: What Are The Lockdown Rules In Different EU Countries?

Cases of COVID-19 are rising in many parts of the European Union. Consequently, some governments have decided to shut down many areas of public...

22,000 Foreigners Vaccinated In Three Days

Director of the Office for Information Technologies and Electronic Administration Mihailo Jovanovic announced that more than 22,000 foreigners were vaccinated in Serbia in three...

Government Of Serbia Adopts Set Of Financial Bills

The Serbian government adopted today a set of bills in the field of finance, including legal solutions on the COVID-19 relief aid in the...

New Measures Against Coronavirus In Force As Of Monday At 6 am

The COVID-19 Crisis Response Team proposed new measures to suppress the epidemic, which will be valid from tomorrow, 22 March at 6 am. Due...

J&J To Make Up To Three Billion COVID-19 Vaccines In 2022

Johnson & Johnson’s chief scientist said the company expects to produce up to 3 billion doses of its COVID-19 vaccine next year, after the...